Rapid Nutrition PLC Makes ZGI Euronext Small Cap HealthTech

We are pleased to announce that The Zephirin Group has highlighted Rapid Nutrition PLC (ALRPD) in their recent report on the ZGI Euronext Small Cap HealthTech. According to the report, Rapid Nutrition has had a strong start to 2024, showcasing significant growth in the company's total revenues.

The Zephirin Group emphasizes that Rapid Nutrition's commitment to innovative health technologies continues to bolster the company's revenues and enhance its brand value. As a part of the ZGI Euronext HealthTech Small Cap, Rapid Nutrition PLC is recognized for its innovative approach among small-cap health technology companies on Euronext Paris.

We are excited about the positive trajectory and look forward to further growth in 2024 and beyond. Thank you for your continued support.

Rapid Nutrition PLC


About Rapid Nutrition

Rapid Nutrition is a leading health and wellness company committed to providing innovative solutions for a healthier world. With a focus on research-backed formulas, we empower individuals to optimize their well-being and face life's challenges with confidence.

Investor Relations Contact:






This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and or otherwise that involve risks, uncertainties and assumptions that could cause Rapid Nutrition PLCs actual results and experience to differ materially from anticipated results and expectations expressed in these forward-looking statements. Rapid Nutrition PLC has in some cases identified forward-looking statements by using words such as "anticipates," "believes," "hopes," "estimates," "looks," "expects," "plans," "intends," "goal," "potential," "may," "suggest," and similar expressions. Rapid Nutrition PLC undertakes no obligation to release publicly the results of any revisions to any such forward-looking statements that may be made to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events, except as required by applicable law or regulation.

This media information does not constitute an offer to sell, or a solicitation of an offer to buy, any securities. This information does not constitute an offering prospectus within the meaning within the meaning of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 of June 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market, and repealing Directive 2003/71 or a listing prospectus within the meaning of the listing rules of the Euronext Exchange or OTC Markets. The media release is in accordance with International Reporting Standard: Rule 12g3-2(b) under the Securities Exchange Act ('Rule 12g3-2(b)') permits non-U.S. companies with securities listed primarily on a Qualified Foreign Exchange to make publicly available to U.S investors in English the same information that is made publicly available in their home countries as an alternative to SEC reporting Exchange Act Rule 12g3-2(b).

Subscribe for Updates